Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veysel Sabri Hancer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Syndromology|April 17, 2023
The First Congenital Disorders of Glycosylation Patient (Fetus) with Homozygous <i>COG5</i> c.95T>G VariantMurat Buyukdogan, Veysel Sabri Hancer, Ayhan Sucak
Medical Oncology (Northwood, London, England)|January 26, 2011
Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patientsVeysel Sabri Hancer, Reyhan Diz-Kucukkaya, Melih Aktan
Cell Biochemistry and Function|September 24, 2004
Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) lociVeysel Sabri Hancer, Reyhan Diz-Kucukkaya, Meliha Nalcaci
Journal of Cytology|December 1, 2018
Prevalence of Human Papilloma Virus Types in Turkish and Albanian WomenVeysel Sabri Hancer, Murat Buyukdogan, Ilta Bylykbashi, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|September 21, 2020
New indicator of cellular ischemia in coronary slow-flow phenomenon: Cell-free DNAMustafa Yolcu, Ali Dogan, Nuri Kurtoglu, et al.
Journal of Thrombosis and Thrombolysis|June 9, 2009
The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndromeReyhan Diz-Kucukkaya, Veysel Sabri Hancer, Bahar Artim-Esen, et al.
Annals of Hematology|May 18, 2011
Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasmAhmet Emre Eskazan, Ayse Salihoglu, Reyhan Diz-Kucukkaya, et al.
Leukemia & Lymphoma|December 8, 2010
Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemiaVeysel Sabri Hancer, Murat Kose, Reyhan Diz-Kucukkaya, et al.
Pediatric Nephrology (Berlin, Germany)|August 21, 2012
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutationF Semsa Cayci, Nilgun Cakar, Veysel Sabri Hancer, et al.
Journal of Thrombosis and Thrombolysis|May 10, 2012
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosisIpek Yonal, Binnur Pinarbası, Fehmi Hindilerden, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Syndromology|April 17, 2023
The First Congenital Disorders of Glycosylation Patient (Fetus) with Homozygous <i>COG5</i> c.95T>G VariantMurat Buyukdogan, Veysel Sabri Hancer, Ayhan Sucak
Medical Oncology (Northwood, London, England)|January 26, 2011
Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patientsVeysel Sabri Hancer, Reyhan Diz-Kucukkaya, Melih Aktan
Cell Biochemistry and Function|September 24, 2004
Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) lociVeysel Sabri Hancer, Reyhan Diz-Kucukkaya, Meliha Nalcaci
Journal of Cytology|December 1, 2018
Prevalence of Human Papilloma Virus Types in Turkish and Albanian WomenVeysel Sabri Hancer, Murat Buyukdogan, Ilta Bylykbashi, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|September 21, 2020
New indicator of cellular ischemia in coronary slow-flow phenomenon: Cell-free DNAMustafa Yolcu, Ali Dogan, Nuri Kurtoglu, et al.
Journal of Thrombosis and Thrombolysis|June 9, 2009
The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndromeReyhan Diz-Kucukkaya, Veysel Sabri Hancer, Bahar Artim-Esen, et al.
Annals of Hematology|May 18, 2011
Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasmAhmet Emre Eskazan, Ayse Salihoglu, Reyhan Diz-Kucukkaya, et al.
Leukemia & Lymphoma|December 8, 2010
Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemiaVeysel Sabri Hancer, Murat Kose, Reyhan Diz-Kucukkaya, et al.
Pediatric Nephrology (Berlin, Germany)|August 21, 2012
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutationF Semsa Cayci, Nilgun Cakar, Veysel Sabri Hancer, et al.
Journal of Thrombosis and Thrombolysis|May 10, 2012
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosisIpek Yonal, Binnur Pinarbası, Fehmi Hindilerden, et al.
Pageof 3